Purchase Order N3239825P0306
Award Date
6/24/25
Potential Completion Date
6/23/28
Potential Value
$105K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Frederick, MD 21702, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Northeast Area of the federal agency to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The $15,078.24 contract is for a MiSeq silver support plan, which provides maintenance and technical support services for Illumina's MiSeq sequencing system. The award does not have a set-aside designation. Illumina has a history of providing a range of sequencing platforms, consumables, and bioinformatics products to...
This federal contract award is for a MISEQ SILVER SUPPORT PLAN from Illumina, Inc., a biotechnology company that specializes in genetic sequencing and genomic analysis technologies. The contract has a ceiling value of $66,284.86 and is a firm fixed-price purchase order with a completion date of September 26, 2026. The funding agency is the Bureau of Medicine and Surgery, a defense agency. The contract does not have a set-aside designation. Illumina, Inc. is the prime contractor, and there is...
This is a $84,332.60 firm fixed price purchase order contract awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc. for a MiSeq Silver Support Plan. The contract has an ultimate completion date of August 14, 2026 and was awarded on August 15, 2020. This award does not have a set-aside designation. Illumina, a manufacturer of sequencing and array-based solutions, has previously received federal contracts and subcontracts from agencies like NIH, CDC, USDA, and VA...
This is a definitive contract awarded by the Office of Administrative Services Procurement Management Branch, a civilian federal agency, to Illumina, Inc., a leading manufacturer and provider of genetic sequencing and genomic analysis technologies. The contract, valued at $1,093,137.47, is for the maintenance of 15 MiSeq DNA sequencing instruments under the MiSeq Silver Support Plan. The contract is a firm fixed-price agreement with a performance period extending through July 5, 2029. Illumina...
The U.S. government agency awarded a $12,888.96 firm fixed-price purchase order contract to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The "MISEQ SILVER SUPPORT PLAN" contract, which does not have a set-aside designation, is for the provision of maintenance and support services for the agency's MiSeq sequencing platform. Illumina, Inc., the prime contractor, is a for-profit manufacturer of goods headquartered in San...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract provides a MiSeq Silver Support Plan with a ceiling value of $13,250.00 and an ultimate completion date of January 2, 2021. Illumina has a long history of providing sequencing systems and related products and services to support research and diagnostics across...
This is a firm-fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. for a MiSeq support plan. The contract has a ceiling value of $85,029.08 and a period of performance through September 11, 2029. Illumina, a manufacturer of genetic sequencing instruments and reagents, has provided a range of sequencing products and services to support research and diagnostics across various...
This federal contract award to Illumina, Inc. is for the provision of a MiSeq Silver Support Plan, which includes the supply of genetic analysis products and services for a one-year period from December 1, 2020 to November 30, 2021. The contract, awarded on a firm fixed price basis with no set-aside, has a ceiling value of $12,888.97. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, has a history of providing similar products and support services to various...
This firm fixed price delivery order contract was awarded by the Southeast Area office of a civilian federal agency to Illumina, Inc. for a MiSeQ Silver Support Plan, at a ceiling value of $20,500.27. The contract does not have a set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided sequencing systems, reagents, and services to support research and diagnostics across various government agencies....
This federal contract award to Illumina, Inc., a pioneering biotechnology company specializing in genetic sequencing and genomic analysis, is for the delivery of a MiSeq System, MiSeq Silver Support Plan, MiSeq Reagent Kit V3 - 600-Cycle, Nextera XT Index Kit - 24 Indexes, 96 Samples, and installation services. The total ceiling value of the contract is $104,933.59. The award was made on August 25, 2020, with a completion date of September 25, 2020. The contract was awarded by a civilian agency,...